CCR5 antagonists: 3-(pyrrolidin-1-yl)propionic acid analogues with potent anti-HIV activity

被引：17
|
作者：
Lynch, CL
Hale, JJ
Budhu, RJ
Gentry, AL
Finke, PE
Caldwell, CG
Mills, SG
MacCoss, M
Shen, DM
Chapman, KT
Malkowitz, L
Springer, MS
Gould, SL
DeMartino, JA
Siciliano, SJ
Cascieri, MA
Carella, A
Carver, G
Karen, H
Schleif, WA
Danzeisen, R
Hazuda, D
Kessler, J
Lineberger, J
Miller, M
Emini, E
机构：
[1] Merck Res Labs, Dept Med Chem, Rahway, NJ 07065 USA
[2] Merck Res Labs, Dept Immunol Res, Rahway, NJ 07065 USA
[3] Merck Res Labs, Dept Antiviral Res, W Point, PA 19486 USA
来源：
ORGANIC LETTERS | 2003年 / 5卷 / 14期
关键词：
D O I：
10.1021/ol034707c
中图分类号：
O62 [有机化学];
学科分类号：
070303 ; 081704 ;
摘要：
graphic A novel approach to alpha,alpha-disubstituted-beta-amino acids (beta(2,2)-amino acids) was employed in the synthesis of a series of 3-(pyrrolidin-1-yl)-propionic acids possessing high affinity for the CCR5 receptor and potent anti-HIV activity. The rat pharmacokinetics for these new analogues featured higher bioavailabilities and lower rates of clearance as compared to cyclopentane 1.
引用
收藏
页码：2473 / 2475
页数：3
相关论文
共 50 条
  • [11] Potent Anti-HIV Chemokine Analogs Direct Post-Endocytic Sorting of CCR5
    Boensch, Claudia
    Munteanu, Mihaela
    Rossitto-Borlat, Irene
    Fuerstenberg, Alexandre
    Hartley, Oliver
    PLOS ONE, 2015, 10 (04):
  • [12] Synthesis and biological evaluation of 1,3,3,4-tetrasubstituted pyrrolidine CCR5 receptor antagonists. Discovery of a potent and orally bioavailable anti-HIV agent
    Ma, Dawei
    Yu, Shanghai
    Li, Ben
    Chen, Li
    Chen, Renhai
    Yu, Kunqian
    Zhang, Linqi
    Chen, Zhiwei
    Zhong, Dafang
    Gong, Zheng
    Wang, Renxiao
    Jiang, Hualiang
    Pei, Gang
    CHEMMEDCHEM, 2007, 2 (02) : 187 - 193
  • [13] 3-({5-Bromo-4-[pyrrolidin-1-yl]pyrimidin-2-yl}amino)phenol
    Jones, Alan M.
    MOLBANK, 2015, (02)
  • [14] 1,3,4-trisubstituted pyrrolidine CCR5 receptor antagonists. Part 2: Lead optimization affording selective, orally bioavailable compounds with potent anti-HIV activity
    Hale, JJ
    Budhu, RJ
    Holson, EB
    Finke, PE
    Oates, B
    Mills, SG
    MacCoss, M
    Gould, SL
    DeMartino, JA
    Springer, MS
    Siciliano, S
    Malkowitz, L
    Schleif, WA
    Hazuda, D
    Miller, M
    Kessler, J
    Danzeisen, R
    Holmes, K
    Lineberger, J
    Carella, A
    Carver, G
    Emini, E
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2001, 11 (20) : 2741 - 2745
  • [15] Synthesis, SAR, and biological evaluation of oximino-piperidino-piperidine amides. 1. Orally bioavailable CCR5 receptor antagonists with potent anti-HIV activity
    Palani, A
    Shapiro, S
    Josien, H
    Bara, T
    Clader, JW
    Greenlee, WJ
    Cox, K
    Strizki, JM
    Baroudy, BM
    JOURNAL OF MEDICINAL CHEMISTRY, 2002, 45 (14) : 3143 - 3160
  • [16] Synthesis, crystal structure and DFT study of (3-(pyrrolidin-1-yl)-5-(trifluoromethyl)phenyl)boronic acid
    Ma, Li-Xue
    Shi, Yuan
    Li, Jin-Lan
    Yang, Bai-Hui
    Yang, Yan
    Zhou, Zhi-Xu
    Huang, Zhu-Yan
    MOLECULAR CRYSTALS AND LIQUID CRYSTALS, 2023, 765 (01) : 65 - 75
  • [17] Structural determinants of the anti-HIV activity of a CCR5 antagonist derived from Toxoplasma gondii
    Yarovinsky, F
    Andersen, JF
    King, LR
    Caspar, P
    Aliberti, J
    Golding, H
    Sher, A
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (51) : 53635 - 53642
  • [18] Syntheses and SAR studies of 4-(heteroarylpiperdin-1-yl-methyl)pyrrolidin-1-yl-acetic acid antagonists of the human CCR5 chemokine receptor
    Shankaran, K
    Donnelly, KL
    Shah, SK
    Guthikonda, RN
    MacCoss, M
    Mills, SG
    Gould, SL
    Malkowitz, L
    Siciliano, SJ
    Springer, MS
    Carella, A
    Carver, G
    Hazuda, D
    Holmes, K
    Kessler, J
    Lineberger, J
    Miller, MD
    Emini, EA
    Schleif, WA
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2004, 14 (13) : 3419 - 3424
  • [19] Studies on the structure-activity relationship of 1,3,3,4-tetra-substituted pyrrolidine embodied CCR5 receptor antagonists. Part 2: Discovery of highly potent anti-HIV agents
    Li, Ben
    Jones, Eric Dale
    Zhou, Enkun
    Chen, Li
    Baylis, Dean Cameron
    Yu, Shanghai
    Wang, Miao
    He, Xing
    Coates, Jonathan Alan Victor
    Rhodes, David Ian
    Pei, Gang
    Deadman, John Joseph
    Xie, Xin
    Ma, Dawei
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2010, 20 (17) : 5334 - 5336
  • [20] Natural proteolytic processing of hemofiltrate CC chemokine 1 generates a potent CC chemokine receptor (CCR)1 and CCR5 agonist with anti-HIV properties
    Detheux, M
    Ständker, L
    Vakili, J
    Münch, J
    Forssmann, U
    Adermann, K
    Pöhlmann, S
    Vassart, G
    Kirchhoff, F
    Parmentier, M
    Forssmann, WG
    JOURNAL OF EXPERIMENTAL MEDICINE, 2000, 192 (10) : 1501 - 1508
12345